Monday, October 12, 2020 9:19:40 AM
US Patent - 15/100,780 PRODUCTION OF THAPSIGARGINS BY THAPSIA CELL SUSPENSION CULTURE. Original denial of Patent was reversed on 7/29/2020, Patent Fees have been paid and Patent was "Dispatched to FDC" (Final Data Capture Stage)
FDC sent on 10/9/2020
Read for yourself in screenshot below
Patent will be granted within the next 5 weeks
Recent RBSH News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
